Eloxx Pharmaceuticals Inc (ELOX)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$
Buy
$
$ (+%)
Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases.
Prices updated at 08 May 2025, 01:39
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Aug 2025 |
| Annual report | May 2025 |
| Annual general meeting | May 2025 |
| Final results | - |
| Previous date | |
|---|---|
| Annual report | Apr 2024 |
| Half yearly results | Aug 2023 |
| Annual general meeting | Jun 2023 |
Company reports
31 Dec 2022
Annual Report 30 Sep 2023
Quarterly Report 